![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » EP MedSystems Begins Enrollment in ICE CHIP Trial
EP MedSystems Begins Enrollment in ICE CHIP Trial
May 5, 2005
EP MedSystems, a company specializing in electrophysiology products used in cardiac rhythm management, announced initiation of the landmark ICE CHIP (Intracardiac Echocardiography guided Cardioversion to Help Interventional Procedures) multicenter clinical trial. This is EP MedSystems' first clinical trial involving intracardiac ultrasound (ICE). The ICE CHIP trial is a sequential Phase I and Phase II worldwide clinical trial, which compares the cardiac imaging capabilities of ICE during a cardiac catheterization procedure with standard transesophageal echocardiography.
Newark dBusinessNews (http://newark.dbusinessnews.com/shownews.php?newsid=23875&type_news=latest)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct